← Back to Search

12-week videoconferencing behavioural support intervention to promote physical activity behaviour for Cancer

N/A

Waitlist Available

Research Sponsored by University of Ottawa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of study (24 months)

Awards & highlights

Study Summary

This trial is testing a new way to help young adult cancer survivors be more physically active, in hopes of improving their quality and length of life.

Eligible Conditions

Cancer
Survivorship

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of study (24 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of study (24 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of study (24 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the trial and intervention

Adherence rates

Data completeness: Qualitative interviews

+3 more

Secondary outcome measures

Anxiety symptoms: 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7; Kroenke, Spitzer & Williams, 2006)

Autonomy support, structure and interpersonal involvement: Health Care Climate Questionnaire (Marcus et al., 1992)

Basic psychological need satisfaction in relation to physical activity: Psychological Need Satisfaction in Exercise Scale (PNSE; Wilson, Rogers & Rodgers, 2006)

+6 more

Other outcome measures

Socio-Demographic and Medical Information Questionnaire

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group A: Videoconferencing interventionExperimental Treatment1 Intervention

Participants allocated to group A will receive a behavioural support intervention via real-time videoconferencing.

Group II: Group B: Usual careActive Control1 Intervention

Participants allocated to group B will receive usual care and will be advised to continue with their regular activities of daily living.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

12-week videoconferencing behavioural support intervention to promote physical activity behaviour

2021

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor

205 Previous Clinical Trials

266,049 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the recruitment size of this trial?

"Verified. Clinicaltrials.gov states that this medical experiment, which opened for recruitment on March 1st 2021, is still accepting patients to participate in the trial. 40 individuals need to be recruited from a single centre."

Answered by AI

Am I eligible to partake in this experiment?

"Individuals between the ages of 18 and 39 with malignancies are eligible for inclusion in this experiment. All participants must have a healthcare professional's approval, as well as regular access to videoconferencing tools like Skype or Google Hangouts."

Answered by AI

Are there any vacancies still available for participating in this experiment?

"Per information hosted on clinicaltrials.gov, this research is in search of participants as we speak. This endeavor was first published on March 1st 2021 and has since been updated on May 16th 2022."

Answered by AI

Are individuals aged 30 years and over able to partake in this clinical experiment?

"As per the requirements of this clinical trial, only individuals aged between 18 and 39 are allowed to enroll."

Answered by AI

What is the main goal of this clinical investigation?

"This clinical trial seeks to measure patients' adherence rates over a two-year timeframe. Secondary objectives include assessing physical activity behaviour, depressive symptoms and health-related quality of life through the use of accelerometers (ActiGraph GT3X+), Patient Health Questionnaire Depression Scale (PHQ-9) and Rand 36-Item Short Form Health Survey (SF-36). Scores on each metric will be tracked across baseline, post intervention and follow up periods."

Answered by AI

Recent research and studies

Journal of Personality and Social PsychologyJournal

Development and Validation of Brief Measures of Positive and Negative Affect: The PANAS Scales.

Watson, David, Lee Anna Clark, and Auke Tellegen. 1988. “Development and Validation of Brief Measures of Positive and Negative Affect: The PANAS Scales.”. Journal of Personality and Social Psychology. American Psychological Association (APA). doi:10.1037/0022-3514.54.6.1063.

Archives of Internal MedicineJournal

A Brief Measure for Assessing Generalized Anxiety Disorder

Spitzer, Robert L., Kurt Kroenke, Janet B. W. Williams, and Bernd Löwe. 2006. “A Brief Measure for Assessing Generalized Anxiety Disorder”. Archives of Internal Medicine. American Medical Association (AMA). doi:10.1001/archinte.166.10.1092.

Acta OrthopaedicaJournal

Patient-reported Outcome Measures in Arthroplasty Registries

Rolfson, Ola, Kate Eresian Chenok, Eric Bohm, Anne Lübbeke, Geke Denissen, Jennifer Dunn, Stephen Lyman, et al.. 2016. “Patient-reported Outcome Measures in Arthroplasty Registries”. Acta Orthopaedica. Medical Journals Sweden AB. doi:10.1080/17453674.2016.1181815.

Journal of Adolescent and Young Adult OncologyJournal